Magnit

Regulatory Filings • Jul 10, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

PJSC MAGNIT - Launch of Pharmacy Project

PR Newswire

London, July 10

Press Release

Krasnodar

July 10, 2017

Magnit Has Opened Four Test Pharmacies

Krasnodar, July 10, 2017: Magnit PJSC, one of Russia’s leading retailers (the “Company”; MOEX and LSE: MGNT) announces the launch of the pharmacy project.

Please be informed that the Company has opened four test pharmacies “Magnit Apteka” in Krasnodar in its convenience stores and hypermarkets. The format offers low prices, high demand assortment, advanced and efficient store organization.

Average assortment consists of over 3,500 SKUs. Together with pharmaceutical goods the store offers skin care, beauty and sanitary products, nutrition, medical devices, seasonal products.

For further information, please contact:

Timothy Post	Head of Investor Relations Email: post@magnit.ru Office: +7-861-277-4554 x 17600
Investor Relations Office	MagnitIR@magnit.ru Direct Line: +7-861-277-4562 Website: ir.magnit.com/
Media Inquiries	Media Relations Department press@magnit.ru

Company description:

Public Joint Stock Company “Magnit” is one of Russia's leading retailers. Founded in 1994, the company is headquartered in the southern Russian city of Krasnodar. As of March 31, 2017, Magnit operated 35 distribution centers and 14,089 stores (10,540 convenience, 427 hypermarkets and 3,122 drogerie stores) in 2,494 cities and towns throughout 7 federal regions of the Russian Federation.

In accordance with the audited IFRS results for 2016, Magnit had revenues of RUB 1,075 billion and an EBITDA of RUB 108 billion. Magnit's local shares are traded on the Moscow Exchange (MOEX: MGNT) and its GDRs on the London Stock Exchange (LSE: MGNT) and it has a credit rating from Standard & Poor's of BB+. Measured by market capitalization, Magnit is one of the largest retailers in Europe.